Responses
Regular and young investigator award abstracts
Clinical trials in progress
319 Phase II trial of immunotherapy in primary glioblastoma: antigens from self-renewing autologous tumor cells presented by autologous dendritic cell vaccine
Compose a Response to This Article
Other responses
No responses have been published for this article.
